Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial
- PMID: 26254513
- DOI: 10.1016/j.diabres.2015.05.030
Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial
Abstract
This study shows that pioglitazone 7.5 mg/day as an add-on therapy in Southeast Asian patients with Type 2 diabetes is safer and equally efficacious as the 15- and 30-mg doses of pioglitazone. Hence it is prudent to start pioglitazone therapy at a lower dose of 7.5 mg/day.
Keywords: Insulin resistance; Low dose; Pioglitazone; Thiazolidinediones; Type 2 diabetes.
Copyright © 2015. Published by Elsevier Ireland Ltd.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
